Medicare Just Dealt Enrollees a Huge Blow in 2026

Medicare will roll back broad telehealth coverage for many services effective Jan. 31, forcing beneficiaries to resume in-person visits for a wide range of care while continuing to allow remote behavioral and mental health services. The change may push some seniors toward Medicare Advantage plans that could maintain expanded telehealth benefits and has potential implications for telehealth providers, care-access services and patient transportation demand, though it is unlikely to be a major market-moving event.

Analysis

Market structure: Medicare’s rollback of broad telehealth coverage (effective Jan 31) redistributes demand from standalone telehealth vendors toward Medicare Advantage plans, in-person outpatient clinics, transportation and home-health services. Expect insurers with large MA footprints (UNH, HUM, CVS/AET) to gain pricing power and enrollment leverage over 6–24 months while pure-play telehealth (TDOC, AMWL) faces a near-term revenue hit concentrated in Medicare segments.

Risk assessment: Tail risks include CMS reversing the change or litigation reinstating coverage (high impact, low prob) and accelerated MA benefit expansion (high prob) that erodes commercial telehealth margins. Immediate shock to usage will show in weekly utilization data within 0–8 weeks; earnings revisions should materialize over the next 1–3 quarters. Hidden dependency: RPM reimbursement codes and broadband access will determine how much care shifts to device-makers (DXCM, ABT, MASI).

Trade implications: Favor long MA insurers and select remote-monitoring device makers, short concentrated telehealth providers. Consider option structures around earnings and CMS announcements (1–3 month horizons) to express conviction while limiting downside. Reallocate 2–4% sector weight from small-cap telehealth into insurers/home-health and device exposure over the next 2–8 weeks.

Contrarian angle: The market may over-penalize telehealth names that derive <30% revenue from Medicare; commercial and behavioral telehealth (allowed) can offset losses if companies pivot quickly. Historical parallel: temporary pandemic-era rollbacks were partly reversed, so size positions conservatively and watch MA plan benefit filings and CMS bulletins (next 30–90 days) for a regime change signal.

Key Decisions for Investors

• Establish a 2–3% portfolio long position split 60/40 between UNH and HUM over the next 7–30 days to capture Medicare Advantage enrollment and telehealth-bundling benefits; target +15–25% upside in 6–12 months, stop-loss at -10%.
• Deploy a 1–1.5% tactical short or buy 3-month put spreads on TDOC and AMWL (size each 0.5–0.75% notional) to hedge near-term Medicare revenue risk; aim for payoff if shares fall >15% after Jan 31 utilization data; close on CMS reversal or after 90 days.
• Initiate a 1.5–2.5% long exposure to RPM/device names ABT, DXCM, MASI for 6–18 months to capture increased demand for in-home monitoring; take profits at +20–30% or cut at -12% if quarterly RPM adoption metrics disappoint.
• Execute a pair trade: long UNH (1.5%) vs short TDOC (0.75%) over 3–9 months to express MA tailwind vs telehealth headwind; rebalance if CMS issues clarifying guidance or if quarterly Medicare revenue mix for telehealth shifts by >10% QoQ.